Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | FAAH | O00519 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22444030 | 1.00 | TRPV1 (0.38) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL3797798 | 1.00 | TRPV1 (0.38) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL3188730 | 1.00 | TRPV1 (0.38) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL20262121 | 1.00 | TRPV1 (0.38) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL3188739 | 1.00 | TRPV1 (0.38) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL3397325 | 1.00 | — | — | |
| SCHEMBL3397326 | 1.00 | — | — | |
| SCHEMBL15918572 | 0.85 | TSHR (0.32) | — | |
| SCHEMBL1300794 | 0.82 | HIF1A (0.37) | TRPV1HIF1AFAAHALDH1A1 | |
| SCHEMBL1300369 | 0.82 | HIF1A (0.37) | TRPV1HIF1AFAAHALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 15 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2391596-B1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2018-06-20 | — | — | EP | claimed |
| US-8212082-B2 | Process for the isolation of dodecatrienal and its use as aroma substance | BASF SE (DE) | 2012-07-03 | — | — | US | claimed |
| EP-2391596-A1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2011-12-07 | — | — | EP | claimed |
| WO-2010086313-A1 | METHOD FOR ISOLATING DODECATRIENAL AND USE THEREOF AS A FLAVOURING | BASF SE (DE) | 2010-08-05 | — | — | WO | claimed |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | BASF SE (DE) | 2010-07-29 | — | — | US | claimed |
| CN-113631694-B | Use of 4,8, 11-dodecatriene aldehyde for imparting clean fragrance impression to compositions | 巴斯夫欧洲公司 | 2024-10-25 | — | — | CN | disclosed |
| US-20220154099-A1 | USE OF 4,8,11-DODECATRIENAL TO IMPART A CLEAN AROMA IMPRESSION TO A COMPOSITION | BASF SE (GI) | 2022-05-19 | — | — | US | disclosed |
| EP-3938485-A1 | USE OF 4,8,11-DODECATRIENAL TO IMPART A CLEAN AROMA IMPRESSION TO A COMPOSITION | BASF SE (DE) | 2022-01-19 | — | — | EP | disclosed |
| WO-2020187733-A1 | USE OF 4,8,11-DODECATRIENAL TO IMPART A CLEAN AROMA IMPRESSION TO A COMPOSITION. | BASF SE (DE) | 2020-09-24 | — | — | WO | disclosed |
| US-8212082-B2 | Process for the isolation of dodecatrienal and its use as aroma substance | BASF SE (DE) | 2012-07-03 | — | — | US | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-8188320-B2 | Process for preparing pure cyclododecanone | BASF SE (DE) | 2012-05-29 | — | — | US | disclosed |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | BASF SE (DE) | 2010-07-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100191018-A1 | PROCESS FOR PREPARING PURE CYCLODODECANONE | CCNA1, CYC1, CCNA2 | TRPV1 3615/4885HIF1A 558/4885FAAH 2771/4885 |
| US-20100190869-A1 | PROCESS FOR THE ISOLATION OF DODECATRIENAL AND ITS USE AS AROMA SUBSTANCE | CCNA1, OXER1, CCNA2 | TRPV1 1196/4885HIF1A 172/4885FAAH 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.